BioPharma Dive5d
FDA approves first-of-its-kind antibiotic from GSK
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
News-Medical.Net5d
C. diff uses toxic compound to gain competitive advantage in the gut
The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills ...
Nature5d
New antibiotic that kills drug-resistant bacteria discovered in technician’s garden
The molecule was found in soil samples collected from a laboratory technician’s garden. The discovery shows that “there is ...
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
C&EN25d
Escherichia coli Surface Display: Advances and Applications in Biocatalysis
National Engineering Research Center for Biotechnology, College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, P.R. China State Key Laboratory of ...
Pharmaceutical Technology26d
WuXi Biologics introduces E coli expression system
Credit: Saiful52/Shutterstock. WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins and plasmid DNA (pDNA). The worldwide market ...
C&EN28d
Optimization of l-Fucose Biosynthesis in Escherichia coli through Pathway Engineering and Mixed Carbon Source Strategy
Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui 230601, China Institute of Plasma Physics, Hefei Institutes of Physical Science, Chinese Academy of Sciences, ...